This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Anthony

Otley

Professor of Pediatrics & Medicine IWK Health Centre/Dalhousie University Dr Otley is a pediatric gastroenterologist at the IWK Health Centre here in Halifax, and a Professor of Pediatrics & Medicine at Dalhousie. He has been in practice for over 20 years and has learned some of the ins and outs of how to transition pediatric patients (and their parents) to adult care ...succeeding some of the time, and learning from when it was not so successful!

Ana Maria

Passos-Castilho

Postdoctoral Fellow Lady Davis Institute, Jewish General Hospital Ana Maria is a Postdoctoral Fellow at the Centre for Clinical Epidemiology at the Lady Davis Institute of the Jewish General Hospital at Montreal. She received her PhD in Infectious Diseases with a focus in Virology at the Federal University of Sao Paulo, Brazil, where she studied new technologies for hepatocellular carcinoma screening and the epidemiology of viral hepatitis. Her current work includes using linked health administrative databases to study the hepatitis C care cascade and HCV-related outcomes with the aim of informing policy towards HCV elimination.

Juan-Nicolas

Pena-Sanchez

Associate Professor Department of Community Health & Epidemiology, College of Medicine, University of Saskatchewan Dr. Juan-Nicolás Peña-Sánchez is an Assistant Professor in the Department of Community Health and Epidemiology of the College of Medicine, University of Saskatchewan. He is a physician from Colombia with a European Master of Public Health, and a Ph.D. from the University of Saskatchewan. His research program aims to promote innovative health care approaches that address the needs of populations and overcome the challenges of health care systems. Since 2018, Dr. Peña-Sánchez has been working in partnership with Indigenous patient and family advocates to raise awareness about inflammatory bowel disease (IBD) among Indigenous peoples and advocate for better access to IBD care and their well-being. In addition, he is the Inclusion, Diversity, and Equity Co-Champion of the Training Researchers in the Next Generation in Gastroenterology and Liver (TRIANGLE) program.

Larissa Lucena

Perico

Postdoctoral Fellow University of Calgary Degrees:  - Bachelor's degree in Pharmacy, Brazil (2007-2010), - a Master's degree in Pharmacology from São Paulo State University, Brazil (2012-2014), - Ph.D. in Pharmacology and Biotechnology from São Paulo State University (2014-2018). Larissa joined the MacNaughton lab as a Postdoctoral Fellow in March 2019. Awards: 2020-until now:  received a postdoctoral fellowship awarded by the Canadian Association of Gastroenterology in partnership with the Canadian Institutes of Health Research (CIHR). Publications:  17 published papers and 3 published book chapters.

Dana

Philpott

Professor University of Toronto Dana Philpott is a Professor and Associate Chair, Research, in the Department of Immunology at the University of Toronto and a Canadian Research Chair, Tier 1, in Microbe-Host interactions in intestinal homeostasis. Dr. Philpott’s research employs animal models of inflammatory bowel disease (IBD) and considers how innate immunity and the microbiome shape immune homeostasis within the intestine. Specifically, her group studies three genes implicated in the pathogenesis of the IBD, Crohn’s disease: NOD2, ATG16L1 and LRRK2. Dr. Philpott’s work aims to define new disease mechanisms and potential new targets for therapy for this increasingly prevalent chronic disorder.

Maria Ines

Pinto Sanchez

Assistant Professor McMaster University Dr. Pinto-Sanchez is a Gastroenterologist and Clinician Nutrition Specialist. She is an active medical staff in the Gastroenterology Division at McMaster University and Hamilton Health Sciences, where she provides consultation services in the area of Gastroenterology and Nutrition. She is the director of the Adult Celiac Clinic at McMaster University and provides care in the intestinal failure clinic and Home Parenteral Nutrition Program. Her clinical and research interests include diagnosing and treating different gastrointestinal conditions with a focus on celiac disease and nutrition.

Massimo

Pinzani

Professor of Medicine, Sheila Sherlock Chair of Hepatology UCL Institute for Liver and Digestive Health Massimo Pinzani is Professor of Medicine at University College London (UCL), London, United Kingdom. He is a clinical and translational hepatologist, Sheila Sherlock Chair of Hepatology and Director of the UCL Institute for Liver and Digestive Health, Division of Medicine. He is one of the pioneers in the research dedicated to cellular and molecular mechanisms of liver fibrosis and relative diagnostic and therapeutic approaches. Current research is centred on regenerative medicine and on the development of extracellular matrix scaffold of liver, pancreas and small intestine for cell bioengineering and 3D disease modelling. Professor Pinzani research activity is summarised in 298 original peer-reviewed publications (H Index of 104, Scopus). He has served in the governing and scientific boards of major international organization in Hepatology and Gastroenterology, and as Editor in Chief and Associate Editor of top peer reviewed international journals in Gastroenterology and Hepatology. He served as Educational Councillor and member of the governing board of the European Association for the Study of the Liver (EASL). He is co-founder and Chair of SAB of Engitix Therapeutics Ltd, an UCL spin-off company dedicated to extracellular matrix-based drug discovery for tissue fibrosis and cancer in the liver and digestive system.

Alexander

Ploss

Professor of Molecular Biology Princeton University Alexander Ploss completed his Ph.D. in Immunology at Memorial Sloan-Kettering Cancer Center and Cornell University and postdoctoral training at The Rockefeller University in New York City. He was member of faculty at The Rockefeller University before joining Princeton University in 2013. Dr. Ploss is a Professor of Molecular Biology, member of the executive committee of the Center Health and Wellbeing and a fellow in the Program in Global Health and Health Policy at Princeton University. He is also a full member of the Cancer Institute of New Jersey. Dr. Ploss’ lab is interested in human-tropic viral pathogens, including but not limited to hepatitis viruses, classical flaviviruses such as Zika, yellow fever and dengue viruses – and since the beginning of the pandemic SARS-CoV-2. In support and recognition of his work Dr. Ploss received numerous awards including the including the Astella’s Young Investigator Award from the Infectious Disease Society of America, the Liver Scholar Award from the American Liver Foundation, the Löffler-Frosch Prize from the German Society of Virology, Merck Irving Sigal Memorial Award from the American Society for Microbiology, and the Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award.

Gemma

Postill

MD/PhD Student University of Toronto Gemma Postill is an MD/PhD student at the University of Toronto. She completed her undergraduate degree at Western University where she studied One Health, which looks at the intersection of human, animal, and environmental health. During her undergraduate degree, she developed an interest in data science and the positive impact that can be made through applying statistics methodology to electronic health records. This led Gemma to working with Dr. Eric Benchimol and Dr. Ellen Kuenzig at the Hospital for Sick Children in Toronto; together they are seeking better understand the unmet healthcare needs of those with inflammatory bowel disease. Gemma is excited to share their findings at the 2023 CCDW Conference — especially as she grew up in Halifax!

Marco

Puglia

Associate professor McMaster University Dr. Marco Puglia is a Gastroenterologist and Hepatologist at McMaster University. He graduated from medical school at the University of Ottawa. He completed Internal Medicine and Gastroenterology training at McMaster University. He then completed a fellowship in Hepatology and Liver Transplant at the University of Toronto. His clinical interests include the management of viral hepatitis, fatty liver disease, hepatocellular carcinoma and pre- and post-liver transplant patients. His academic interests include teaching at both the undergraduate and postgraduate level and participation in clinical trials.

Paolo

Raggi

Professor of Medicine-Cardiology University of Alberta, Edmonton, AB Paolo Raggi, MD, is a Professor of Medicine and Cardiology at the University of Alberta in Edmonton, AB. He is also an Adjunct Professor of Radiology and Professor of Epidemiology at Emory University in Atlanta, GA, USA. Dr. Raggi received his MD degree Summa Cum Laude from the University of Bologna, in Bologna, Italy. He has published over 450 peer-reviewed articles and 30 book chapters on the topics of atherosclerosis imaging, vascular calcification, lipid metabolism, cardiovascular disease associated with chronic kidney disease, rheumatological disorders, HIV infection, diabetes mellitus, the metabolic syndrome and the impact of mental health disorders on coronary artery disease.

Adam

Rahman

Associate professor of Medecine Western University After training in internal medicine and gastroenterology in Ontario, Dr. Rahman completed advanced training in clinical nutrition at the University of Chicago. He subsequently training in critical medicine medicine at the University of Toronto at Sunnybrook Health Sciences Centre. He has completed his Master’s of Clinical Epidemiology at the University of Toronto. Dr. Rahman's career is to develop a programmatic program of research focusing on nutritional interventions to improve muscle mass and function in patients with serious illness.

Sara

Rahmani

PhD Candidate McMaster University PhD Candidate in Drs. Elena Verdu and Tohid Didar's labs at McMaster University, School of Biomedical Engineering

Mandip

Rai

Gastroenterologist Queen's University Dr. Mandip Rai is an Assistant Professor in the Division of Gastroenterology at Queen’s University. He completed gastroenterology training at Queen’s University. He went on to complete his fellowship in advanced therapeutic endoscopy at St. Michael’s Hospital, University of Toronto (2022). He is currently completing a Master of Science in evidence-based health care at the University of Oxford. Dr. Rai’s clinical and academic interests centre around therapeutic endoscopy and pancreaticobiliary disease.

Maitreyi

Raman

Associate Professor of Medicine University of Calgary Dr. Maitreyi Raman is a Gastroenterologist and Physician Nutrition Specialist, Associate Professor of Medicine in the Department of Medicine and Division of Gastroenterology at the University of Calgary. She completed medical school at the University of Ottawa, and then Internal Medicine Residency at Dalhousie University, and subsequently a clinical nutrition fellowship at the University of Toronto. Dr. Raman has clinical and research interests in lifestyle as primary therapy for patients with digestive diseases. She investigates using dietary patterns, components, nutrients and fasting in the management of digestive health disorders, and investigates the role of diet to modulate the gut microbiome and chronic inflammation in Inflammatory Bowel Diseases, IBS and NAFLD. In addition, Dr. Raman explores the role of the brain-gut axis through mind body interventions, and its impact on chronic disease outcomes

David

Reed

Assistant Professor Queen's University A clinician-scientist in the GI Diseases Research Unit at Queen's University

Lisa

Reynolds

Assistant Professor University of Victoria Dr. Reynolds completed her PhD at the University of Edinburgh, UK, and then moved to Vancouver to carry out postdoctoral research at the University of British Columbia. Dr. Reynolds joined the University of Victoria as an Assistant Professor in 2017. Research in the Reynolds laboratory focuses on the multi-directional interactions between the mammalian immune system and intestine-dwelling organisms including helminths and the bacterial microbiota, with a view to understanding how these interactions affect mammalian health in a variety of inflammatory and infectious disease contexts.

Kwestan

Safari

PhD Student University of British Columbia Kwestan Safari is a fourth year PhD student working in Dr. Laura Sly’s lab at the University of British Columbia and BC Children’s Hospital, in Vancouver, Canada. Her research focuses on understanding and elucidating mechanisms of fibrosis in Crohn’s Disease (CD) using a mouse model that captures key characteristics observed in humans. More specifically, she is investigating whether genetic ablation and blocking of IL-4 and/or IL-13 signaling can reduce or potentially reverse intestinal fibrosis in hopes of developing a first-in-kind therapy for CD-associated intestinal fibrosis.

Richard

Schreiber

Emeritus Professor and Professor of Pediatrics UBC/Mcgill University Dr. Richard Schreiber is Emeritus Professor of Pediatrics Faculty of Medicine at the University of British Columbia and Professor of Pediatrics, Faculty of Medicine, McGill University.
Rick obtained his medical degree at McGill University in 1981, completed an internship in internal medicine at the Montreal General Hospital, followed by four years of residency in Pediatrics at the Montreal Children’s Hospital. He was the chief medical resident at the Children’s.
Dr. Schreiber then spent three years in fellowship training at Harvard University in the Combined Program of Pediatric Gastroenterology Hepatology and Nutrition at the Massachusetts General Hospital and Boston Children’s Hospital (1986-89). He returned to McGill University to the Division of Pediatric Gastroenterology in 1990.
Rick moved to British Columbia in 1997 and joined the medical faculty at UBC and BC Children’s Hospital.
As an active member of the Division, Rick established the pediatric liver program at BCCH. This is a nationally and internationally recognized program in pediatric hepatology that provides high quality of care to British Columbian children with liver disease. He developed several care pathways and protocols for the management of liver disease at the hospital. He worked with BC Special Authority to successfully implement a drug coverage plan for infants affected by rare cholestatic liver disease. He helped to spearhead the BC provincial protocol for the delivery of maternal IVIG in pregnancy, to prevent Gestational Alloimmune Liver Disease (GALD), a major cause of newborn liver failure. He worked with the BC MOH on the Viral Hepatitis Committee to set standards of care for BC children affected with hepatitis B and C. He established the BC laboratory protocol to include a fractionated bilirubin in all requestions for bilirubin testing in BC infants aged 7 days to one year. His was the first program in North America to integrate the use of Fibroscan© into pediatric liver care as a non-invasive method to assess infants and children for hepatic fibrosis (cirrhosis) in place of having to do an invasive liver biopsy. 
Dr. Schreiber initiated and has been the Director of the BC Pediatric Liver Transplant Program since 1998. He helped to create and establish the provincial Pediatric Multiorgan Transplant Clinic that offers a multidisciplinary team approach to family centered outpatient care for all British Columbian children who received a solid organ transplant.
Dr. Schreiber was the BCCH medical lead to develop a Provincial Pediatric Complex Hepatobiliary Program. This is a multidisciplinary program that aims to provide advanced tertiary and quarternary level comprehensive care to the 100 or so BC children affected annually with rare congenital, infectious, inflammatory, metabolic, vascular, neoplastic and genetic liver disease. The program has been approved by BCCH and PHSA and is awaiting resource approval by the BC MOH.
Aside from Dr. Schreiber’s achievements in the clinical domain, Rick has had a longstanding clinical research career with interest in pediatric liver disease including biliary atresia, viral hepatitis, metabolic/genetic liver disease and immune hepatobiliary disease. A landmark achievement was his CIHR funded research to determine the feasibility and cost effectiveness of a stool colour card program to screen for biliary atresia (BA). This seminal Canadian-based research led to the establishment of a home-based stool colour card screening program for BA in British Columbia under the auspices of Perinatal Services BC. This was the first screening program for BA in Canada and in North America. The program is currently being implemented by Newborn Screen Ontario.
Dr. Schreiber helped to establish the Canadian Pediatric Hepatology Research Group (CPHRG), a national collaborative of every pediatric hepatologist in Canada. He was the co-chair of the CPHRG through to 2018. The CPHRG has co-ordinated several multicentered national studies on pediatric liver disease. These Canadian-based studies have provided data on rare orphan pediatric liver disease outcomes. This work is recognized worldwide for its uniquely large sample-size and highly powered pediatric research design.
Dr. Schreiber has published over 100 manuscripts, book chapters, abstracts, summary reviews and editorials in peer reviewed high impact journals. He serves as a regular reviewer for major journals including Journal of Pediatrics, Pediatrics, JAMA, Hepatology, and Journal of Pediatric Gastroenterology and Nutrition. He is an Associate Editor of the Canadian Liver Journal.
Dr Schreiber has provided regular education sessions to medical students, residents and fellows and has consistently received high marks for his teaching. He was on the organizing committee for the Canadian Association of Gastroenterology Resident- In-Training course (GRIT) for 5 years. He has organized national postgraduate educational programs for the annual meetings of the Canadian Association of Gastroenterology, NASPGHAN and the Canadian Association for the Study of Liver Disease. He was on the international organizing committee for the Biliary Atresia and Related Diseases conference in Belgium in June 2022. Dr. Schreiber has delivered many lectures and CME presentations. He has been a frequent and regular invited speaker and keynote speaker to several medical conferences and educational programs in BC, across Canada, the US and internationally.
Dr. Schreiber served as President of the Canadian Association for the Study of Liver Disease. (CASL) from 2016-2018. CASL is a multidisciplinary group of scientists and healthcare providers whose expertise focuses on the liver and provides national leadership in all aspects of research education and patient care as they pertain to the liver. As President, Rick established the Canadian Liver Meeting as the premier forum for hepatology education in Canada. He created the Canadian Liver Journal, CASL’s official publication, which has now been recognized as an international liver journal and has been successfully registered with PUBMED. He reignited the society’s annual single topic conference that aims to provide high level research discussion and knowledge translation in focused areas of liver health. He recently chaired the CASL strategic plan committee.
Dr. Schreiber is currently on the Board of Directors of the Canadian Liver Foundation and on its finance committee. He led the current CLF strategic plan. He has been a long-time member of NIH Drug Safety Monitoring board for the Non-Alcoholic Steatohepatitis (NASH) Consortium. He has served as an expert medical consultant to the CADTH advisory committee on Mar-trientene use in Wilson disease. He is a Medical Advisor for the CH.i.L.D. foundation, the philanthropic organization established by Ms. Grace McCarthy to support research in pediatric GI and Liver Disease.
In 2014, he was nominated to the inaugural class of Fellows of the American Association of the Study of Liver Disease (FAASLD). This is the highest honour among AASLD membership categories in recognition of superior professional achievement in clinical or academic practice in liver disease. Dr. Schreiber was the honoree for the 2016 Canadian Liver Foundation Gala in Vancouver BC. In 2018 he was the keynote speaker at the CHiLD foundation Doorman Dinner. Dr. Schreiber received the 2021 CASL Distinguished Service Award and Medal for his contributions to CASL and the Canadian hepatology community at large. In January 2022, Dr. Schreiber was recognized as an Expertscape “Expert” in Biliary Atresia. Expertscape's Pub Med-based algorithms on peer-reviewed publications in scientific journals, placed him in the top 1% of scholars writing about Biliary Atresia over the past 10 years.
Rick is married to Cheryl Brownstein. He has two step-children, Matthew and Roslyn, and is the proud grandfather of Isabelle and Benjamin. He now lives in Montreal working part time at McGill and he enjoys being with his grandchildren aged 2 and 4, especially during their formative years of growth and development.

Giada

Sebastiani

Associate Professor McGill University Health Centre Giada Sebastiani is Associate Professor of Medicine and Research Director in the Division of Gastroenterology of Hepatology at McGill University. She received a medical degree and specialized in internal medicine at the University of Padua, Italy. She had research training at Harvard Medical School (US), University College of London (UK), University of Bordeaux (France), Lady Davis Institute for Medical Research (Montreal, Canada). Her work focuses on fatty liver disease (NAFLD), liver fibrosis and non-invasive diagnostic tools in liver disease. She is author of 140 articles in peer-reviewed journals (including Lancet Digital Health, Gastroenterology, Hepatology, Journal of Hepatology, Clinical Infectious Diseases; h-index=41, citations=7,500), 13 book chapters, 230 conference publications. Dr Sebastiani is founding and steering committee member of the Canadian NASH Network and the sole North American representative in the guidelines of the European AIDS Clinical Society. Dr Sebastiani was awarded the prestigious Senior Clinical Research Salary Award from Fonds Recherche Sante Quebec. Her research program is funded by the Canadian Institute of Health Research, the CIHR Canadian HIV Trials Network and the Fonds Recherche Sante Quebec.

Caroline

Seiler

PhD Candidate McMaster University Caroline is a 4th-year PhD candidate in the Bercik-Collins lab at McMaster University where she researches how gluten and wheat affect patients with irritable bowel syndrome. She has conducted meta-analyses on the association between inflammatory bowel diseases and celiac disease as well as probiotics and celiac disease and is interested in using and investigating different statistical methods.

Abdel-Aziz

Shaheen

Associate Professor of Medicine University of Calgary Abdel Aziz Shaheen (MD, MPH) is an Associate Professor of Gastroenterology and Hepatology at the University of Calgary. He is a Gastroenterologist and Epidemiologist. His research interests focus on developing new models of care for patients with chronic liver diseases, particularly patients with non-alcoholic fatty liver disease and alcohol-related liver disease. Furthermore, Dr. Shaheen is interested in studying the natural history of chronic liver diseases in Canada and comparing the diagnostic accuracy of different liver fibrosis modalities. He has published more than 95 papers in international peer reviewed journals. His research program is funded through multiple CIHR, provincial, national, and international grants.

Rebecca

Shapiro

Assistant Professor University of Guelph Rebecca Shapiro is an Assistant Professor in Molecular and Cellular Biology at the University of Guelph, with research interests in fungal pathogenesis, functional genomics, and microbial engineering. The research in Dr. Shapiro’s lab focuses on developing CRISPR-based tools for functional genomic analysis, with applications to studying virulence and drug resistance in fungal pathogens. Dr. Shapiro is a Tier II Canada Research Chair in Microbial Functional Genomics and Synthetic Biology and is a CIFAR Azrieli Global Scholar in the Fungal Kingdom program.

Sowmya

Sharma

Advanced IBD Fellowship Johns Hopkins University School of Medicine Dr. Sharma is a Canadian-trained Gastroenterologist, having finished her GI residency in this beautiful city of Halifax. She is currently doing her IBD Fellowship at Johns Hopkins in Baltimore. She enjoys cooking, travelling, and has recently joined a Baltimore hip-hop dance group, which she continues to be humbled with.

Ben

Shneider

Head of Pediatric Gastroenterology, Hepatology and Nutrition - Professor of Pediatrics Baylor College of Medicine/Texas Children's Hospital Dr. Benjamin L. Shneider is the George Peterkin Endowed Chair and Head of the Section of Pediatric Gastroenterology, Hepatology and Nutrition at the Baylor College of Medicine and Texas Children’s Hospital. Dr. Shneider is a Pediatric Hepatologist actively involved in clinical and translational investigations of pediatric liver diseases. He graduated from The University of Chicago School of Medicine, completed a residency in Pediatrics at The Children’s Hospital, Boston and a fellowship in Pediatric Gastroenterology/Hepatology at the Yale University. Dr. Shneider is a member of the American Society of Clinical Investigators and the American Pediatric Society.

Jocelyn

Silvester

Assistant Professor Boston Children's Hospital Dr Jocelyn Silvester is Assistant Professor of Pediatrics at Harvard Medical School. After completing her PhD in biology at the University of Cambridge, she attended Dalhousie Medical School, completed a Pediatric Residency at the University of Manitoba and Pediatric Gastroenterology fellowship at Boston Children's Hospital. Her research interests include the diagnosis and management of celiac disease with a particular interest in what happens after the diagnosis of celiac disease is made.

Anton

Skaro

Director Liver Transplantation Surgery Western Univetrsity Dr. Skaro completed an undergraduate degree in Biology at the University of Windsor, medical education at the University of Western Ontario and residency in General Surgery at Dalhousie University in Halifax Nova Scotia. During surgical residency, Dr. Skaro obtained a PhD in transplantation immunology and later completed fellowship training in pediatric and adult multi-organ transplant surgery at Northwestern University in Chicago. He stayed at Northwestern as an Associate Professor of Surgery for 12 years before finally returning back to Canada after being heavily recruited to be the Director of Liver Transplantation at Western University and London Health Sciences Centre. He has performed hundreds of successful liver, kidney, pancreas, and intestinal transplants in adults and children. And when not transplanting he performs open, minimally invasive and robotic hepatopancreatobiliary oncology procedures. Dr. Skaro has authored more than 100 peer-reviewed publications, book chapters, and abstracts. He has presented his research in transplantation and served prominently on committees nationally and internationally. Aside from speaking at conferences around the globe, has been interviewed for popular culture media outlets including Fox News, The Atlantic, and Science Daily. He has been awarded grant funding from the National Institutes of Health in the US and the Canadian Institute for Health Research. He has personally trained more than 30 Transplant Surgeons, and countless residents, medical and undergraduate students and has been formally recognized for his excellence in teaching.

Ludvig

Sollid

Professor University of Oslo Ludvig M. Sollid (MD, PhD) is a Professor at the University of Oslo and a Senior Consultant at the Oslo University Hospital - Rikshospitalet. He is also the Director of UiO FOCIS Centre of Excellence. His research interests are focused around genetics and immunology of autoimmune diseases.
His group has made important contributions to the understanding of the molecular basis of celiac disease, in particular the role of HLA genes, the existence of gluten reactive (HLA-DQ restricted) T cells in the celiac intestinal lesion, the identification of immunotoxic gluten peptide sequences and the involvement of the transglutaminase 2 in the pathogenesis of the disease. His group is currently working on the characterization of the antigen receptors of T cells and B cells that recognize the celiac disease relevant antigens gluten and transglutaminase 2.
Sollid is the recipient of several research awards including the Research Council of Norway's Møbius Prize for Outstanding Research, the Warren Prize for Excellence in Celiac Disease Research, the Rank Prize in Nutrition, the UEG Research Prize and the Jahre Nordic Medical Prize (junior award 1998 and senior award 2015). He currently serves on the editorial boards of Mucosal Immunology, Scandinavian Journal of Immunology, HLA, Genes and Immunity and Gastroenterology.

Sean

Spencer

Physician Scientist Stanford University Sean Spencer, MD,PhD is a Gastroenterologist and Physician Scientist at Stanford University working with Justin Sonennburg,PhD to uncover the role of dietary intake on the gut microbiome and mucosal immune system. Sean obtained his medical degree University of Pennsylvania, earning his PhD studying nutritional immunology with Yasmine Belkaid,PhD at the National Institutes of Health (NIH), after which he moved to Boston for residency training at Massachusetts General Hospital and completed his Gastroenterology training at Stanford University. Sean’s career goal is to study mechanisms by which dietary intake influences our microbiome and immune system to better understand and treat gastrointestinal disease.

Mark

Swain

Professor of Medicine University of Calgary Dr. Mark Swain is a hepatologist and Professor of Medicine at the University of Calgary. He holds the Cal Wenzel Family Foundation Chair in Hepatology. Dr. Swain has longstanding research and clinical interests in improving the management and treatment of people with autoimmune, viral and metabolic liver disease. He is President of the Canadian Association for the Study of the Liver (CASL) and was inducted as a Fellow of the Canadian Academy of Health Sciences in 2019 for his accomplishments in liver disease.

Nicholas

Talley

Distinguished Laureate Professor University of Newcastle Professor Talley is a distinguished physician scientist and gastroenterologist, with a special interest in functional and inflammatory gastrointestinal diseases including eosinophilic gut diseases. He is currently a Distinguished Laureate Professor of Medicine at the University of Newcastle and a Senior Staff Specialist at the John Hunter Hospital. He is a past Editor-in-Chief of the Medical Journal of Australia and a member of the NHMRC Council. He has an outstanding highly cited academic track-record with over 1100 publications. He holds an NHMRC Investigator Grant, is Chief Investigator (CIA) on a NHMRC Centre of Research Excellence (CRE) in Digestive Health and is a chief investigator on several other successfully completed NHMRC and NIH grants, and has attracted funding worth more than AUD$10 million dollars in the last 10 years. Nick has won several prestigious research awards is invited to deliver lectures and present his research around the world, and is considered an international authority in the field.

Edward

Tam

Clinical Hepatologist Pacific Gasroenterology Associates Dr. Edward Tam is a Clinical Hepatologist in Vancouver, BC

Farzaneh

Tamnanloo

PhD student University of Montreal Farzaneh Tamnanloo is a Ph.D. candidate in Biomedical science – experimental medicine at Université de Montréal. Currently, she is performing her Ph.D. in the Hepato-Neuro laboratory under the supervision of Dr. Christopher Rose. She is a fundamental researcher and had worked with several animal models of hepatic encephalopathy. Her focus is on hepatic encephalopathy and its implications on neurodegeneration and neuronal injury.

Puneeta

Tandon

University of Alberta Dr. Tandon is a Professor of Medicine, Co-Director of the Cirrhosis Care Clinic and Transplant Hepatologist at the University of Alberta in Edmonton, Alberta, Canada. Her clinical practice and research are focused on cirrhosis with research interests including frailty and the use of digital strategies to optimize physical and mental health in individuals living with chronic disease. It is her career goal to provide wholistic, interdisciplinary, evidence based, patient-centered care through education, empowerment, engagement and team-work.

Shilpa

Tandon

Masters Student McMaster University Shilpa is a current Masters student in Medical Sciences at McMaster University in Hamilton, ON. She completed her undergraduate degree in Life Sciences also from McMaster. She currently conducts clinical research on nutrient deficiency and dietary therapy in celiac disease under her supervisor Dr. Pinto-Sanchez at the Farncombe Family Digestive Health Research Institute.

Elliot

Tapper

Associate Professor University of Michigan Associate Professor, Director of the Cirrhosis Program at the University of Michigan. Editor-in-chief of Hepatology Communications

Laura

Targownik

University of Toronto University of Toronto Dr. Laura Targownik is currently a Clinician Researcher in the Mount Sinai Hospital Inflammatory Bowel Disease Clinic and is a member of the Zane Cohen Centre for Gastrointestinal Research. She is also the Director for the University of Toronto Division of Gastroenterology and Hepatology and is a faculty member of the University of Toronto School of Public Health Institute for Health Policy, Management and Evaluation. Dr. Targownik is a member of numerous research consortia, including the Canadian IBD Research Consortium, the Canadian Gastrointestinal Epidemiology Consortium and the TRIANGLE Health Researcher Training Platform. She is also the part chair for Equity and Diversity for the Canadian Association of Gastroenterology, and is the Current head of GI Women CAN!, where she is spearheading several initiatives with the aim of improving the representation of women in positions of leadership and influence in gastroenterology. Her current focus of research is in using secondarily collected data sources to evaluate the costs and benefits of medications used in IBD, assessing how to optimize delivery of mental health care for persons with IBD in diverse practice settings, and on assessing the impact of patient and physician gender on the patient journey and associated outcomes

Jennifer

Telford

Clinical Professor of Medicine University of British Columbia Dr. Jennifer Telford is a gastroenterologist at St. Paul's Hospital in Vancouver. She is a Clinical Professor of Medicine at the University of British Columbia and the Medical Director for the BC Colon Screening Program.

Anouar

Teriaky

Assistant Professor Western University Dr. Anouar Teriaky is an Assistant Professor of Medicine at Western University, a Clinician Teacher in the Department of Medicine, Division of Gastroenterology and Hepatology. He is the Medical Director of Liver Transplantation at London Health Sciences Centre. He completed his Bachelor of Science with Honours in Biochemistry at the University of Ottawa followed by his MD at the University of Ottawa. He trained in Internal Medicine residency and Gastroenterology fellowship at Western University. Dr. Teriaky completed further training in Transplant and General Hepatology at the University of Chicago Medical Center. He has completed a Master of Public Health at Harvard University. His clinical interests include research on social disparities in liver transplantation, donor derived hepatitis C infection, and  post liver transplant outcomes.

Jill

Tinmouth

Physician Sunnybrook Health Sciences Center Dr. Jill Tinmouth is a gastroenterologist and a clinical epidemiologist. Currently, she is a gastroenterologist at Sunnybrook Health Sciences Center, Scientist at the Sunnybrook Research Institute Inc., an Adjunct Scientist at the Institute for Clinical Evaluative Sciences, and an Associate Professor in the Department of Medicine and the Institute of Health Policy Management and Evaluation at the University of Toronto. She is the Director of Clinical Epidemiology and Health Care Research in the Institute of Health Policy Management and Evaluation. She has been the Lead Scientist for Ontario’s colorectal cancer screening program, ColonCancerCheck, since May 2011. Her research focuses on screening for colorectal cancer as well as colonoscopy quality improvement and health service utilization.

Quentin K

Tsang

PhD Student Queen's University Quentin is currently a PhD candidate in the labs of David Reed and Stephen Vanner at the Gastrointestinal Diseases Research Unit, Queen's University. He completed his Bachelor of Science - Specialization in Kinesiology at Queen's University. His research interests lie in visceral pain signalling in the gastrointestinal tract, more specifically during inflammatory bowel disease.

Cynthia

Tsien

Hepatologist Toronto General Hospital Dr. Cynthia Tsien, MDCM, MPH, FRCPC, is the Education Director at the Soham & Shaila Ajmera Family Transplant Centre. She completed her residency in Internal Medicine and Gastroenterology at McGill University. She underwent training in hepatology, transplant hepatology, and research at the Toronto General Hospital and Cleveland Clinic. She obtained a Master in Public Health at the John Hopkins University. She specializes in the care of patients with liver disease pre- and post-transplant. Her research interests include sarcopenia, portal hypertension, and education.

Narmeen

Umar

Graduate Research Assistant Fellow University of Alberta I am a Graduate Student at the University of Alberta. My research area is Autoimmune Liver diseases. I am here to present an abstract at the Canadian Liver Meeting.

Katie

Upham

Harm Reduction Educator The Substance User Network of the Atlantic Region (SUNAR) Katie Upham is the Harm Reduction Educator of the Substance User Network of the Atlantic Region (SUNAR). She currently sits on the Board of Directors of the Canadian Association of People Who Use Drugs. She uses her own lived experience with substance use and those of the SUNAR membership to advocate for change in health care settings, drug policies, and other changes to our current systems that support the rights of those with lived/living experience of substance use. She strongly believes that people who use(d) substances must be justly included in all practices, programming and guidelines that concern them.

Michael

Vallis

Associate Professor Family Medicine, Dalhousie University Dr. Vallis is a registered health psychologist based in Halifax, Canada. He is a Health Behaviour Change Consultant and Associate Professor in Family Medicine at Dalhousie University. His main area of expertise is adult health psychology, with an emphasis on obesity, diabetes, cardiovascular risk and gastroenterology. He spends most of his time training healthcare providers in behaviour change for chronic disease management. He regularly supervises clinical and academic students at Dalhousie and is active in research on motivation, behavioural change and adaptation to chronic disease. He consults nationally as well as internationally and is heavily involved in academic publications, journal editing, and clinical practice guidelines (2020 and 2006 Canadian Clinical Practice Guidelines for the Management of Obesity and 2018, 2013, 2004 Diabetes Canada Clinical Practice Guidelines). He was recently awarded a Queen’s Diamond Jubilee Medal by the Government of Canada on the recommendation of the Canadian Diabetes Association.

Stephen

Vanner

Director of the Gastrointestinal Diseases Research Unit Queen's University Dr. Vanner is a clinician scientist at Queen's University and Director of the Gastrointestinal Diseases Research Unit. His research focuses and the pathophysiological of symptoms underlying Disorders of Gut-Brain Interactions and IBD

Elena

Verdú

Professor McMaster University After completing MD studies in Buenos Aires, Argentina, I trained in clinical research at the University of Lausanne, Switzerland. This was followed by a Ph.D. degree at the Institute of Microbiology and Gnotobiology of the Czech Academy of Science on the effect of commensal bacterial antigens in animal models of inflammatory bowel disease and celiac disease. As a post-doctoral fellow at McMaster University, I focused on beneficial (probiotic) bacteria and their effect on gut function and inflammation. AI am currently professor in medicine at the Farncombe Institute, McMaster University. My research program investigates diet-microbe interactions in chronic intestinal inflammatory conditions such as IBD and celiac disease, with the aim to deliver therapies targeting the dietary and microbial drivers of inflammation.

Peter

Vickerman

Professor University of Bristol Peter Vickerman is a Professor in infectious disease modelling with 25 years’ experience in infectious disease modelling. His research focuses on using modelling to help understand the transmission of infectious diseases and impact/cost-effectiveness of prevention measures amongst key populations, especially HIV and HCV.

Hannah Louise

Wallace

PhD Candidate Memorial University Hannah Wallace completed her BSc at the University of New Brunswick - Saint John. She is now a senior PhD Candidate in the lab of Dr. Rod Russell at Memorial University in St John's Newfoundland. Her PhD research focuses on RNA virus-induced cell death and the role cell death plays in pathogenesis. Hannah is a CanHepC trainee and the current trainee representative on the Canadian Society for Virology Executive.

Mark

Walsh

NSHA, Central Zone NSHA, Central Zone HPB Transplant Surgeon, Surgical Lead for the Atlantic Multi Organ Transplant Program.